http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100588799-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4523
filingDate 1998-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100588799-B1
titleOfInvention Benzo (5,6) cyclohepta (1,2-k) pyridine derivatives for inhibiting farnesyl protein transferase and pharmaceutical compositions comprising the same
abstract The present invention relates to the following novel compounds.n n n Formula 25.0n n n n n n n n Formula 29.0n n n n n n n n Formula 38.0n n n n n n n n Chemical Formula 42.0n n n n n n n n Formula 47.0n n n n n n n n Chemical Formula 53.0n n n n n n n n The present invention also relates to methods of inhibiting abnormal growth of cells, methods of inhibiting farnesyl protein transferase, and methods of treating cancer using the novel compounds.n n n Tricyclic amide compounds, farnesyl protein transferase, abnormal growth of cells, activated Ras oncogene, FPT IC50
priorityDate 1997-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9510516-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466187388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141931870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10784524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426737334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10870959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426481550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466230040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466622167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467404571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467117539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465503519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467117540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10602862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466187391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426290695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422814576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421960717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433611899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466639623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468397888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468329488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9818617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468397892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141998042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468264857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426472287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10718853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466624390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468276813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466626980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466639622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10809260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426477704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426478558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10834222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467005874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15895352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15408111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468002348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426719234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468343447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467021320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9809539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465625300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426478380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10766758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163802774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426479968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10792547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20592485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426476129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468365518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466479424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426479148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468126107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466513030

Total number of triples: 89.